Cargando…
Pilot Study to Gain First Indications for the Impact of a 3-Month's Oral Intake of a Sucrosomial Iron Supplement on Hemoglobin in Iron-Deficient Blood Donors
INTRODUCTION: Regular whole blood donors often suffer from iron deficiency (ID) or iron deficiency anemia due to the loss of 200–300 mg of iron with each donation. Hemoglobin (Hb) as donor eligibility criterion reflects iron stores only poorly. ID in blood donors is typically prevented or treated wi...
Autores principales: | Torreiter, Patrick Paul, Drexler-Helmberg, Camilla, Schimetta, Wolfgang, Krakowitzky, Petra, Helmberg, Wolfgang, Schlenke, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521237/ https://www.ncbi.nlm.nih.gov/pubmed/37767276 http://dx.doi.org/10.1159/000527577 |
Ejemplares similares
-
Sucrosomial(®) Iron: A New Generation Iron for Improving Oral Supplementation
por: Gómez-Ramírez, Susana, et al.
Publicado: (2018) -
Pathogen reduction of double‐dose platelet concentrates from pools of eight buffy coats: Product quality, safety, and economic aspects
por: Rosskopf, Konrad, et al.
Publicado: (2020) -
Comparative Evaluation of Sucrosomial Iron and Iron Oxide Nanoparticles as Oral Supplements in Iron Deficiency Anemia in Piglets
por: Mazgaj, Rafał, et al.
Publicado: (2021) -
Sucrosomial(®) Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation
por: Asperti, Michela, et al.
Publicado: (2018) -
Sucrosomial Iron Supplementation for the Treatment of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients Refractory to Oral Iron Treatment
por: Bastida, Guillermo, et al.
Publicado: (2021)